Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, January 8, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Fri, January 5, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Kristen Kluska Initiated (CAPR) at Buy and Held Target at $8 on, Jan 5th, 2024
Kristen Kluska of Cantor Fitzgerald, Initiated "Capricor Therapeutics, Inc." (CAPR) at Buy and Held Target at $8 on, Jan 5th, 2024.
Kristen has made no other calls on CAPR in the last 4 months.
There is 1 other peer that has a rating on CAPR. Out of the 1 peers that are also analyzing CAPR, 0 agree with Kristen's Rating of Hold.
This is the rating of the analyst that currently disagrees with Kristen
- Joseph Pantginis of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $40 on, Wednesday, October 4th, 2023
